---
title: "Missed a dose of NMN or NR? What to know | HealthRX.com"
description: "Missed an NMN or NR dose? Human trials used planned daily dosing and did not test missed doses, so no catch-up rule exists. See the safety data."
url: https://healthrx.com/nad-nmn/missed-dose-protocol
publisher: HealthRX.com
---


HealthRX.com

No catch-up rule exists for missed NMN or NR doses

60% PBMC NAD+ rise over placebo with NR 1,000 mg/day for 6 weeks Source: pubmed.ncbi.nlm.nih.gov

[Print or save as PDF](https://healthrx.com/printables/nad-nmn/missed-dose-protocol?print=1)

Key numbers

- 250 mg/day NMN dose for 12 weeks; raised whole-blood NAD+ in 30 healthy adults Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35479740/), as cited Nov 8, 2026
- 1,250 mg NMN dose once daily for up to 4 weeks; judged safe in 31 healthy adults Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/36002548/), as cited Nov 8, 2026
- 60% PBMC NAD+ rise over placebo with NR 1,000 mg/day for 6 weeks Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/29599478/), as cited Nov 8, 2026
- 25% Rise in insulin-stimulated glucose disposal with NMN 250 mg/day in 25 women with prediabetes Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/33888596/), as cited Nov 8, 2026

[See the public record for NMN (nicotinamide mononucleotide)](https://healthrx.com/data/nmn-nicotinamide-mononucleotide)

HealthRX.com quick answer. There is no evidence-based catch-up schedule, late-dose window or double-dose rule for NMN or NR; the human trials used planned once- or twice-daily dosing and did not report testing missed doses. Both are oral dietary supplements, not FDA-approved drugs, and the trials ran for roughly 3 to 12 weeks. [1][2]

At a glance

- Status / Oral dietary supplements; neither is an FDA-approved drug [1]
- Doses studied / NMN 250 to 1,250 mg/day [3][4][9]; NR 1,000 to 3,000 mg/day [5][6]
- Trial schedules / Daily dosing, once or twice daily, for about 3 to 12 weeks [5][6][7][8]
- Long-term safety / Data beyond about 12 weeks are lacking [2]
- Drug interactions / No human interaction studies of NMN or NR found [2]
- Regulatory note / NMN is treated as lawful in supplements after FDA's 2025 petition response; NDI rules apply [1]

## Doses and durations used in NMN and NR studies

NMN and NR are NAD+ precursors. NMN 250 mg/day for 12 weeks raised whole-blood NAD+ in 30 healthy adults [9]. In a 10-week trial of 25 postmenopausal women with [prediabetes](https://healthrx.com/conditions-prediabetes/diagnosis-algorithm) who were overweight or obese, NMN 250 mg/day raised insulin-stimulated glucose disposal by about 25%; this was a small single-center study, and its analysis was disputed in a published comment [3]. NMN 300, 600 or 900 mg/day for 60 days raised blood NAD+ in 80 middle-aged adults, highest at 600 and 900 mg/day [11]. NMN 1,250 mg once daily for up to 4 weeks was safe in 31 healthy adults [4].

NR trials also used daily schedules. NR 1,000 mg/day for 6 weeks raised PBMC NAD+ about 60% over placebo in 24 adults aged 55 to 79 [5]. NR 1,500 mg twice daily, or 3,000 mg/day, for 4 weeks produced no moderate or severe adverse events in 20 people with Parkinson's disease [6].

## Is there a catch-up or double-dose rule?

No. The trials gave planned daily doses and did not report comparing taking a missed dose late, skipping it, or doubling the next one. The 1,250 mg NMN dose in the safety trial was a planned once-daily dose, not a make-up dose, so it does not show what a doubled dose after a missed day would do [4]. The only missed-dose wording available would be whatever a specific product's own package says.

Questions worth asking

Choose the questions you want to keep Should I take a missed NMN or NR dose late, or skip it? Does the product label give instructions for a missed dose? Is it safe to double my next NMN or NR dose after forgetting one? Which of my prescription medicines could interact with NMN or NR? How long have NMN or NR been studied in people, and what is still unknown? What daily timing routine would help me avoid missing doses?

## Short-term safety and unstudied drug combinations

NMN 1,250 mg/day for up to 4 weeks caused no severe adverse events and no changes beyond normal variation in blood or urine tests [4]. Human trials have generally been short and small, so evidence beyond roughly 12 weeks is limited [2]. No human [drug-interaction](https://healthrx.com/nad-nmn/drug-drug-interactions) studies of NMN or NR were found, so a specific combination with a prescription drug is unstudied rather than proven safe [2].

## A short summary of NMN and NR legal status

NMN is not banned. Trade press reported, though this is not confirmed on fda.gov, that in 2022 FDA told two ingredient makers that NMN was excluded from the dietary supplement definition [12]. FDA's 2025 response to a citizen petition concluded that NMN is not excluded, subject to new-dietary-ingredient notification rules [1]. Neither NMN nor NR is an FDA-approved drug, and no NAD+ precursor is approved to treat aging or any disease [1].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. According to the article, is there an established catch-up schedule for a missed NMN or NR dose?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Printable missed-dose plan

NMN and NR missed-dose record for supplement users

Use this sheet when you take NMN or NR supplements and miss a day. It records your product label wording, your daily intake, and questions to take to your prescriber or pharmacist. No catch-up rule has been established for these supplements.

[Open the fill-in sheet](https://healthrx.com/printables/nad-nmn/missed-dose-protocol) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

What should I do if I miss a dose of NMN or NR?

There is no established catch-up schedule. The trials followed the planned daily schedule and did not report comparing late, skipped or doubled doses. [4][5][6]

What doses were used in human trials?

NMN 250 mg/day for 10 to 12 weeks; NMN 300, 600 or 900 mg/day for 60 days; NMN 1,250 mg once daily for up to 4 weeks; NR 1,000 mg/day for 6 weeks; NR 1,500 mg twice daily for 4 weeks. These are study doses, not an official recommended intake. [3][9][11][4][5][6]

Is NMN FDA-approved?

No. NMN and NR are sold as oral dietary supplements and neither is an FDA-approved drug. In 2025 FDA concluded NMN is not excluded from the supplement definition, subject to new-dietary-ingredient rules. [1]

References

Show all 12 references Hide references

1. FDA response to citizen petition, docket FDA-2023-P-0872, document 2754. Regulations.gov, 2025. [FDA-2023-P-0872-2754](https://www.regulations.gov/document/FDA-2023-P-0872-2754)
2. Freeberg KA, Udovich CC, Martens CR, Seals DR, Craighead DH. [Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions](https://pubmed.ncbi.nlm.nih.gov/37068054/). J Gerontol A Biol Sci Med Sci. 2023;78(12):2435-2448.
3. Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, et al. [Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women](https://pubmed.ncbi.nlm.nih.gov/33888596/). Science. 2021;372(6547):1224-1229.
4. Fukamizu Y, Uchida Y, Shigekawa A, Sato T, Kosaka H, Sakurai T. [Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women](https://pubmed.ncbi.nlm.nih.gov/36002548/). Sci Rep. 2022;12(1):14442.
5. Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, et al. [Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults](https://pubmed.ncbi.nlm.nih.gov/29599478/). Nat Commun. 2018;9(1):1286.
6. Berven H, Kverneng S, Sheard E, Søgnen M, Af Geijerstam SA, Haugarvoll K, et al. [NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/38016950/). Nat Commun. 2023;14(1):7793.
7. Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, et al. [Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures](https://pubmed.ncbi.nlm.nih.gov/31412242/). Cell Rep. 2019;28(7):1717-1728.e6.
8. Dollerup OL, Christensen B, Svart M, Schmidt MS, Sulek K, Ringgaard S, et al. [A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects](https://pubmed.ncbi.nlm.nih.gov/29992272/). Am J Clin Nutr. 2018;108(2):343-353.
9. Okabe K, Yaku K, Uchida Y, Fukamizu Y, Sato T, Sakurai T, et al. [Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects](https://pubmed.ncbi.nlm.nih.gov/35479740/). Front Nutr. 2022;9:868640.
10. Igarashi M, Nakagawa-Nagahama Y, Miura M, Kashiwabara K, Yaku K, Sawada M, et al. [Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men](https://pubmed.ncbi.nlm.nih.gov/35927255/). NPJ Aging. 2022;8(1):5.
11. Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, et al. [The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial](https://pubmed.ncbi.nlm.nih.gov/36482258/). Geroscience. 2023;45(1):29-43.
12. FDA citizen petition docket [FDA-2023-P-0872](https://www.regulations.gov/docket/FDA-2023-P-0872) (NMN dietary supplement status). Regulations.gov.

Next in this cluster

Related reading

- [nicotinamide mononucleotide NMN caffeine](https://healthrx.com/supplements-nad-nmn/with-caffeine)
- [nicotinamide mononucleotide Glutathione NMN interaction](https://healthrx.com/supplements-nad-nmn/with-glutathione)
- [nicotinamide mononucleotide Nad+ in food](https://healthrx.com/lifestyle-nad-nmn/nutrition)
- [nicotinamide mononucleotide NMN L-theanine interaction](https://healthrx.com/supplements-nad-nmn/with-l-theanine)
- [nicotinamide mononucleotide NMN monitoring schedule](https://healthrx.com/nad-nmn/monitoring-schedule)
- [nicotinamide mononucleotide NMN muscle preservation](https://healthrx.com/nad-nmn/muscle-preservation)
- [nicotinamide mononucleotide NMN Off-Label uses](https://healthrx.com/nad-nmn/off-label-uses)
- [nicotinamide mononucleotide NMN dosing older adults](https://healthrx.com/nad-nmn/older-adult-dosing)
- [nicotinamide mononucleotide NMN safety](https://healthrx.com/nad-nmn/older-adult-safety)
- [nicotinamide mononucleotide NMN overdose](https://healthrx.com/nad-nmn/overdose-management)
- [nicotinamide mononucleotide NMN patent](https://healthrx.com/nad-nmn/patent-generic-timeline)
- [nicotinamide mononucleotide NMN pharmacogenomics](https://healthrx.com/nad-nmn/pharmacogenomics)
- [nicotinamide mononucleotide Can I Take Glycine with NMN/NR? Interaction, Safety, and Dosing Guide](https://healthrx.com/supplements-nad-nmn/with-glycine)
- [nicotinamide mononucleotide NMN 5-HTP interaction](https://healthrx.com/supplements-nad-nmn/with-5-htp)

![NMN and NR missed dose: woman checking reminder beside bedside supplement bottle](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/nad-nmn/missed-dose-protocol.webp)

A woman wonders whether to take a forgotten capsule, a question human trials never tested for NMN or NR. Full NMN missed dose guide and sources at [healthrx.com/nad-nmn](https://healthrx.com/nad-nmn).

> Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.
